EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Baclofen Modulates Neural Intrinsic Functional Connectivity in Treatment‐Seeking Individuals With Alcohol Use Disorder

Warren B Logge, Tristan P Hurzeler iD, Paul S Haber, Laurence Mealing, Andrew J Baillie iD, Kirsten C Morley iD

Alcohol, Clinical and Experimental Research · 2026-06 · 50 (6)

DOI: 10.1111/acer.70332 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 05.06.2026. Verfasst von Warren B Logge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Edith Collins Centre for Translational Research in Alcohol, Drugs and Toxicology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney,…. Hauptthemen laut MEDLINE: Alcoholism, Baclofen, Brain, GABA-B Receptor Agonists. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic alcohol use alters brain networks related to reward and stress regulation, contributing to alcohol use disorder (AUD). Baclofen, a GABA B receptor agonist, reduces cue‐elicited neural responses and alcohol consumption, but its effects on intrinsic functional connectivity remain unclear. This study investigates the dose‐specific effects of baclofen on intrinsic resting‐state functional connectivity in treatment‐seeking individuals with AUD.

Methods

In this double‐blind, placebo‐controlled, randomized clinical trial, 29 participants with AUD were randomized to receive placebo ( n = 10), low‐dose baclofen (30 mg/day, n = 10), or high‐dose baclofen (75 mg/day, n = 9) for 12 weeks. Resting‐state fMRI data were collected at rest during week 2. A data‐driven parcellation approach assessed connectivity patterns across the brain and associations with percentage of heavy drinking days and percentage of days abstinent post scan were examined in an exploratory analysis.

Results

Compared to placebo, high‐dose baclofen was associated with significant differences in intrinsic connectivity in brain regions linked with reward, stress, attentional, and salience networks. Higher connectivity was observed between the somatomotor network and regions involved in stress regulation (e.g., hypothalamus) and reward processing, while lower connectivity was observed within salience and attentional networks. These changes were not observed in the low‐dose or placebo groups. Although nonsignificant, associations between MES and clinical outcomes demonstrated moderate, directionally consistent effects for abstinence‐related outcomes.

Conclusions

High‐dose baclofen may modulate intrinsic brain connectivity in key networks implicated in AUD, including systems involved in attention and stress regulation. Although statistically significant relationships between functional connectivity and clinical outcomes were not identified, trends suggest that connectivity differences between high‐dose baclofen and placebo may be relevant to treatment response. These neurobiological findings provide additional support for baclofen as a dose‐dependent pharmacotherapy for AUD and highlight the need for larger samples to clarify the relationship between intrinsic connectivity and clinical outcomes. Trial Registration ClinicalTrials.gov , NCT01711125, https://clinicaltrials.gov/ct2/show/NCT01711125 letter of completion

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismBaclofenBrainGABA-B Receptor AgonistsAdultFemaleHumansMaleMiddle AgedDose-Response Relationship, DrugDouble-Blind MethodMagnetic Resonance ImagingNeural Pathways

Stichwörter der Autor:innen

alcohol use disorderbaclofenfunctional connectivityfunctional magnetic resonance imagingrandomized controlled trial

Substanzen

BaclofenGABA-B Receptor Agonists

Autor:innen und Institutionen

  • Edith Collins Centre for Translational Research in Alcohol, Drugs and Toxicology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, New South Wales, Australia.
  • Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Drug Health Services, Sydney Local Health District, Sydney, New South Wales, Australia.
  • Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Tristan P Hurzeler, Andrew J Baillie, Kirsten C Morley

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Logge, W. B., Hurzeler, T. P., Haber, P. S., Mealing, L., Baillie, A. J., & Morley, K. C. (2026). Baclofen Modulates Neural Intrinsic Functional Connectivity in Treatment‐Seeking Individuals With Alcohol Use Disorder. Alcohol, Clinical and Experimental Research, 50(6). https://doi.org/10.1111/acer.70332

Vancouver

Logge WB, Hurzeler TP, Haber PS, Mealing L, Baillie AJ, Morley KC. Baclofen Modulates Neural Intrinsic Functional Connectivity in Treatment‐Seeking Individuals With Alcohol Use Disorder. Alcohol, Clinical and Experimental Research. 2026;50(6). doi:10.1111/acer.70332

BibTeX
@article{Logge2026,
  author = {Logge, Warren B and Hurzeler, Tristan P and Haber, Paul S and Mealing, Laurence and Baillie, Andrew J and Morley, Kirsten C},
  title = {Baclofen Modulates Neural Intrinsic Functional Connectivity in Treatment‐Seeking Individuals With Alcohol Use Disorder},
  journal = {Alcohol, Clinical and Experimental Research},
  year = {2026},
  volume = {50},
  number = {6},
  doi = {10.1111/acer.70332}
}
Kostenlos starten →